A national surveillance study was conducted to determine trends in antimicrobial resistance patterns among three common causes of community-acquired respiratory tract infections. Fifteen participating U.S. medical centers submitted clinically significant isolates of Haemophilus influenzae, MoraxeeUa (BranhameUla) isolates, 1 (0.2%) was penicillin resistant, while 3.8% were relatively resistant to penicillin, 4.5% were resistant to trimethoprim-sulfamethoxazole, 2.3% were resistant to tetracycline, 1.2% were resistant to chloramphenicol, and 0.2% were resistant to erythromycin. Overall, the lowest resistance rates for these common bacterial respiratory pathogens were noted with amoxicillin-clavulanate, cefuroxime, and cefaclor.
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Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella (Branhamella) catarrhalis are bacterial agents responsible for a number of upper and lower respiratory tract infections, including otitis media (3, 4, 6, 12) , maxillary sinusitis (3, 6, 12, 22) , community-acquired pneumonia (6, 11) , and in some cases, exacerbations of chronic bronchitis (6, 12, 29) . These species may harbor resistance mechanisms which affect several antimicrobial agents commonly used to treat such infections (2, 3, 5, 6, 14, 15, 17, 23, 24, 26, 31) . Two prior national surveillance studies have documented antimicrobial resistance rates of H. influenzae from a variety of infections and in various age groups in the United States (8, 9 ). An catarrhalis was examined for production of P-lactamase by using a nitrocefin-based disk test (Cefinase; Becton Dickinson Microbiology Systems, Cockeysville, Md.).
Chloramphenicol acetyltransferase tests. Selected isolates of S. pneumoniae were examined for production of chloramphenicol acetyltransferase by using a commercial disk test (Remel, Lenexa, Kans.). The method of the manufacturer was modified as described by Matthews et al. (26) . Specifically, enzyme induction was performed before the chloramphenicol acetyltransferase tests were performed by growing the strains overnight on a sheep blood agar plate with inclusion of a 30-p.g chloramphenicol disk. Growth was then taken from around the chloramphenicol inhibition zone margin to prepare the cell suspension for enzyme testing.
RESULTS
The majority of the bacterial respiratory pathogen isolates included in this study were derived from adults with respiratory tract infections (Table 1) . More than 50% of the isolates of all three species were obtained from patients >50 years old. The H. influenzae and S. pneumoniae isolates were recovered from patients with a similar age distribution (Table 2) . Compared with H. influenzae and S. pneumoniae, there were more M. catarrhalis isolates from patients less than 6 months old and fewer isolates from adults aged 16 to 50 years. Male patients generated more than 60% of the isolates of all three species.
The most frequent source from which the three species were recovered was sputum (63.5% of all isolates; Table 2 ). A total of 19.5% of pneumococcal isolates were recovered from the blood of patients with bacteremic pneumonia. Relatively few isolates (<5%) of any of the three species studied were recovered from maxillary sinus aspirates or middle ear fluids.
Overall, 84.1% of the 378 M. catarrhalis and 16.5% of the 564 H. influenzae isolates produced P-lactamase (Table 2) .
,B-Lactamase production by both species was lowest among patients from 21 to 35 years and >80 years of age ( Table 1) . The highest prevalence of ,B-lactamase-producing isolates of both species was documented in those from 6 months to 2 years and 2 to 6 years of age, although the rate of ,-lacta- 29) , blood (n = 20), naso/endotracheal aspirate (n = 5), bronchoscopy/trans tracheal aspirate (n = 4), other or not specified (n = 4).
bIndicates statistically significant (P c 0.05 by chi-square test) difference in prevalence of ,B-lactamase production. mase-producing isolates of H. influenzae in those from 36 to 50 years of age was also significantly greater than the mean rate of all P-lactamase-producing isolates. Only 10.3% of the Haemophilus respiratory isolates represented encapsulated, serotype b strains. Fifty percent of the type b strains were isolated from sputum and 35% were isolated from blood. P-Lactamase production was more common among the type b isolates (29.3%) than among the non-type b strains (15.0%). ,B-Lactamase production among H. influenzae isolates was more frequent among female patients (23% of isolates) than it was among male patients (16%) (P = 0.048; Fisher exact test). Table 3 relates the antimicrobial susceptibilities of the ,B-lactamase-positive and -negative Haemophilus isolates to the 12 drugs included in the study. Ampicillin and amoxicillin demonstrated essentially equivalent activities against the non-enzyme-producing strains. If analyzed collectively without respect to P-lactamase production and using the current NCCLS interpretive criteria (28) for susceptible, intermediate, and resistant categories, overall rates of resistance were 16.5% to ampicillin, 2.1% to tetracycline, 0.7% to trimethoprim-sulfamethoxazole, 1.1% to cefaclor, and <0.2% to amoxicillin-clavulanate and cefuroxime. Erythromycin showed only marginal activity against the H. influenzae strains (Table 3) . No chloramphenicol-resistant strains were recovered during this study. Likewise, there were no isolates which were resistant to ampicillin (MIC, .4 jig/ml) but which did not produce ,B-lactamase. However, there were four strains (0.7%) which were P-lactamase negative, for which an intermediate ampicillin MIC of 2 jig/ml was observed, and for which cephalosporin MICs were 8-to 16-fold higher than those for the other P-lactamase-negative strains.
Penicillin resistance (i.e., MIC, 2 ,ug/ml) was encountered in only a single S. pneumoniae strain (0.2%) isolated from a naso/endotracheal sample from a 10-year-old boy. In addition to penicillin, that isolate was resistant to chloramphenicol, tetracycline, and trimethoprim-sulfamethoxazole. Cephalosporin MICs were also substantially elevated for that strain, e.g., cephalexin, 256 ,ug/ml; cefaclor, 128 jig/ ml; and cefuroxime, 4 ,ug/ml. Relative resistance to penicillin (MICs, 0.12 to 1 p.g/ml) was documented in 3.8% of all pneumococcal isolates, while overall resistance (using NCCLS interpretive criteria [28] ) to trimethoprim-sulfamethoxazole was 4.5%, resistance to tetracycline was 2.3%, resistance to chloramphenicol was 1.2% (because of chloramphenicol acetyltransferase production), and resistance to erythromycin was 0.2% (Table 4 ). The majority (63%) of the relatively penicillin-resistant isolates were recovered from sputum, and only two strains were recovered from blood. Two strains were relatively resistant to penicillin and were also resistant to chloramphenicol, tetracycline, and trimethoprim-sulfamethoxazole. In addition, there were eight strains that were relatively resistant to penicillin and resistant to trimethoprim-sulfamethoxazole; one strain that was resistant to chloramphenicol, tetracycline, and trimethoprim-sulfamethoxazole; and two strains that were resistant to both chloramphenicol and tetracycline. There was not a predominant source of isolation of these multiply resistant strains.
With the notable exception of penicillin, ampicillin, and amoxicillin resistance due to P-lactamase production in 84.1% of the 378 isolates, MICs of the study drug for the M.
catarrhalis isolates were uniformly low (Table 5 ). For P-lactamase-producing strains, MICs of cephalosporins and the ,-lactamase inhibitor combinations were from 2-to 16-fold higher than those for the enzyme-negative strains, although specific guidelines for interpretation of M. catarrhalis MICs have not been described by NCCLS.
DISCUSSION
This study represented an attempt to determine national trends in antimicrobial resistance patterns of three common bacterial pathogens involved in respiratory tract infections. The majority of isolates characterized in this study were recovered from sputum samples from male patients over age 50. Additional samples from upper respiratory sources such as maxillary sinus or middle ear effusions would have been (9) , in which H. influenzae isolates from a variety of infection sites were studied for antimicrobial resistance properties. In particular, the 15.0% rate of P-lactamase production among non-type b strains in the present study was almost identical to the rate among similar strains in the previous study (9) , i.e., 15.6%. While there were relatively fewer type b strains in the current study, the prevalence of strains that produced P-lactamase in this study was also quite similar to that in the aforementioned investigation (9), i.e., 29.3 and 31.7%, respectively. Very similar overall rates of resistance were noted in the two studies (in which identical testing methods were used) with respect to tetracycline (2.0 versus 2.1%, respectively), trimethoprim-sulfamethoxazole (0.7% in both studies), and cefaclor (1.8 versus 1.1%, respectively). The infrequency of cefaclor resistance in this study and the previous study (9) is in contrast to the high rate of resistance (e.g., 60%) reported in two prior multicenter studies (18, 19) . This is perhaps due to the fact that cefaclor MICs are often twofold higher when tested in lysed horse blood supplemented Mueller-Hinton broth (as used by Jones and colleagues [18, 19] ) than in Haemophilus test medium (21) , and perhaps is also due in part to the documented instability of cefaclor in culture medium (20) . These differences may also be a reflection of the relative lability of cefaclor to the TEM-1 ,-lactamase of H. influenzae (19) which may result in elevated MICs at increased inoculum concentrations.
None of the 564 Haemophilus isolates in the present study were chloramphenicol resistant. However, only 14 such strains (0.5%) were detected in the earlier study (9) . The results of this study also confirm the impression that ampicillin-resistant, 3-lactamase-negative strains are exceedingly rare (9) . However, there were four strains for which the ampicillin MIC was 2 ,ug/ml (intermediate) and for which cephalosporin MICs were 8-to 16-fold higher than those for the other ,-lactamase-negative strains, suggesting the presence of modified or low-affinity penicillin-binding proteins (27) .
The rate of relative resistance to penicillin (MICs, 0.125 to 1 ,ug/ml) among pneumococci in this study was somewhat lower than previous studies in the United States have suggested (range, 6.9 to 15.5%) (13) (14) (15) (16) 30) . However, the 3.8% prevalence of such strains in our study was virtually identical to that recently reported by the Centers for Disease Control for systemic isolates recovered in 1987 (Spika et al., 29th ICAAC). Penicillin resistance (MIC, .2 ,ug/ml) was exceedingly rare in the present study; i.e., it was found in only a single strain. The MICs of the cephalosporins included in our study were somewhat elevated with the relatively penicillin-resistant strains (Table 4) and substantially elevated in the lone penicillin-resistant strain. Resistance to trimethoprim-sulfamethoxazole and tetracycline was more common in our study than chloramphenicol resistance was. In fact, the 4.5% resistance to trimethoprimsulfamethoxazole represented the highest rate of pneumococcal resistance among the antimicrobial agents included in this study. However, even higher rates of resistance to this drug combination have been reported in two previous reports (5 to 11.5%) (13, 31) .
The 84.1% prevalence of ,3-lactamase-producing M. catarrhalis demonstrated during this national surveillance study is entirely consistent with previous estimates (3, 6) based on local surveys. This high rate of P-lactamase production supports the notion that M. catarrhalis should be considered as predictably resistant to penicillin and ampicillin-amoxicillin. Results of this study also support the concept that, in the United States, M. catarrhalis is universally susceptible to a wide array of antimicrobial agents which might be chosen for therapy of respiratory infections (1, 7, 10) . Although Brown and colleagues (2) recently reported one erythromycin-resistant and two tetracycline-resistant strains based on MIC testing, our findings support the recommendation of NCCLS (28) that, at present, only 3-lactamase determinations are necessary in the routine testing of M. catarrhalis for susceptibility to antimicrobial agents.
In summary, the antimicrobial agents which showed the best overall in vitro activity against the three common community-acquired bacterial respiratory tract pathogens that we tested were amoxicillin-clavulanate, cefuroxime, cefaclor, chloramphenicol, and to a lesser degree, tetracycline. Resistance was problematic among the other drugs because of differences among species in their susceptibilities to specific agents, e.g., penicillin, ampicillin, and amoxicillin resistance because of P-lactamase production in M. catarrhalis and H. influenzae (and relative resistance in S. pneumoniae), poor erythromycin activity against H. influenzae, and trimethoprim-sulfamethoxazole resistance among pneumococci.
